Cwm, LLC Axogen, Inc. Transaction History

Cwm, LLC

$23.3 Billion
Q3 2024

A detailed history of Cwm, LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Cwm, LLC holds 55 shares of AXGN stock, worth $894. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 17 223.53%

Holding current value

$894

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Oct 08, 2024	BUY	$7.52 - $14.69 $285 - $558	38 Added 223.53%	55 $1,000
Q2 2024 Jul 09, 2024	BUY	$5.67 - $8.06 $96 - $137	17 New	17 $0

Others Institutions Holding AXGN

# of Institutions

162

Shares Held

36.6M

Call Options Held

230K

Put Options Held

400

First Light Asset Management, LLC Edina, MN

4.09M
Shares

$66.5 Million
5.0% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$52.8 Million
0.0% of portfolio
Soleus Capital Management, L.P. Greenwich, CT

3.01M
Shares

$48.9 Million
3.58% of portfolio
Morgan Stanley New York, NY

2.9M
Shares

$47.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$39.4 Million
0.0% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $688M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account